Key Findings
The Asia Pacific dermatological therapeutics market is projected to record a CAGR of 7.96% during the forecast period, 2019-2028. The rising disposable income and the surging number of skin disorders are estimated to be instrumental factors for market growth.

Market Insights
The Asia Pacific dermatological therapeutics market growth evaluation encompasses the analysis of Japan, India, China, Indonesia, South Korea, Vietnam, Thailand, Australia & New Zealand, and the rest of Asia Pacific. Japan has a continuously growing geriatric population. The nation is also ranked among the top when it comes to the rising senior population in the Asia Pacific. Such a steep increase means a rise in the need for frequent services, thereby becoming a potential customer base for dermatological procedures. The country is also among the high-income countries of the Asia Pacific. The rising burden of skin diseases in the countries entails impetigo, warts, acne, atopic dermatitis, etc. Of these, atopic dermatitis was regarded as the most common skin-related disease in the country, as per the National Health and Wellness Survey. In India, there is an increasing demand for new healthcare technological advancements to meet the surging burden of skin diseases. Though WHO states that the developing countries suffer due to poor infrastructure and minimum healthcare facilities, the government initiatives in India are evaluated to be beneficial for market growth. Thus, factors like global warming, rising awareness with regard to personal hygiene, and the increasing aging population, are set to stimulate the growth of the Indian market.

Competitive Insights
Some of the leading companies present in the market are, Merck KGaA, Leo Pharma A/S, Novartis AG, AGI Dermatics, Pfizer Inc, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments